Opinion|Videos|July 22, 2024
Biologic Therapies for Hidradenitis Suppurativa
Author(s)Vivian Shi, MD, FAAD
A dermatologist outlines the role for biologic therapies in the hidradenitis suppurativa treatment landscape and discusses the importance of early intervention.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What is the “window of opportunity” with anti-inflammatory treatments in HS and why is early intervention with biologic therapies so imperative?
- Which biologic therapies are currently used in HS and what are the important patient considerations you consider before utilizing these?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps
2
$20 Billion National Strategy Aims to Close the Women's Health Gap
3
GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH
4
Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women
5